BIOX-TECH

CELLULAR MEDICINE SCIENCE AND RESEARCH CENTER

​

BIOX-TECH is developing new innovative treatments based on stem cells and similar advanced therapies. The Center is dedicated to fundamentally changing how treat diabetes, heart disease, and autoimmune and degenerative conditions such as rheumatoid arthritis, Alzheimer’s Disease, and Parkinson’s Disease, and CTE

Working in collaboration with universities and private companies worldwide, the company will also focus on innovations to improve immunity, increase longevity, and reduce the impact of aging.

The company’s scientists and epidemiologists previously collaborated on a team that received approval for one of the first clinical trials to study using stem cell therapy to treat COVID-19.

​

​

Eric’s Role: Cofounder and Chairman of the Board

​

BIOX-TECH has a fully integrated lab & biobanking center.
Clinical Scale – ISO-7 suite, ISO-9, ISO-13, ISO-14 labs ALL GMP-LIKE

​

​